Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-062277
Filing Date
2024-03-07
Accepted
2024-03-07 16:48:39
Documents
6
Effectiveness Date
2024-03-07

Document Format Files

Seq Description Document Type Size
1 S-8 d748506ds8.htm S-8 30475
2 EX-5.1 d748506dex51.htm EX-5.1 5574
3 EX-23.1 d748506dex231.htm EX-23.1 1388
4 EX-FILING FEES d748506dexfilingfees.htm EX-FILING FEES 18846
5 GRAPHIC g748506g0305171915343.jpg GRAPHIC 2380
6 GRAPHIC g748506g0305171915554.jpg GRAPHIC 3698
  Complete submission text file 0001193125-24-062277.txt   66243
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277752 | Film No.: 24730907
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)